Works matching IS 00071048 AND DT 2022 AND VI 196 AND IP 2

Results: 36
    1

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    2
    3
    4
    5
    6
    7

    Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 414, doi. 10.1111/bjh.17897
    By:
    • Musallam, Khaled M.;
    • Vitrano, Angela;
    • Meloni, Antonella;
    • Addario Pollina, Sebastiano;
    • Di Marco, Vito;
    • Hussain Ansari, Saqib;
    • Filosa, Aldo;
    • Ricchi, Paolo;
    • Ceci, Adriana;
    • Daar, Shahina;
    • Vlachaki, Efthymia;
    • Singer, Sylvia T.;
    • Naserullah, Zaki A.;
    • Pepe, Alessia;
    • Scondotto, Salvatore;
    • Dardanoni, Gabriella;
    • Karimi, Mehran;
    • El‐Beshlawy, Amal;
    • Hajipour, Mahmoud;
    • Bonifazi, Fedele
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 424, doi. 10.1111/bjh.17847
    By:
    • Ying, Lianghong;
    • Wang, Jing;
    • Li, Juan;
    • Teng, Jianzhen;
    • Zhang, Xiaofeng;
    • Ullah, Inam;
    • Samee, Abdus;
    • Xu, Ke;
    • Chen, Jun;
    • Xu, Lei;
    • Zhu, Hui;
    • Li, Jimin;
    • Yang, Lu;
    • Wang, Fei;
    • Fan, Yuansheng;
    • Zhang, Jing;
    • Lu, Yi;
    • Gong, Xiaoxuan;
    • Shi, Lu;
    • Eikelboom, John W.
    Publication type:
    Article
    14
    15

    Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Fotiou, Despina;
    • Papanagnou, Eleni‐Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 360, doi. 10.1111/bjh.17818
    By:
    • Gastinne, Thomas;
    • Le Bourgeois, Amandine;
    • Coste‐Burel, Marianne;
    • Guillaume, Thierry;
    • Peterlin, Pierre;
    • Garnier, Alice;
    • Imbert, Berthe‐Marie;
    • Drumel, Thomas;
    • Mahe, Beatrice;
    • Dubruille, Viviane;
    • Blin, Nicolas;
    • Lok, Anne;
    • Touzeau, Cyrille;
    • Tessoulin, Benoit;
    • Jullien, Maxime;
    • Vanthygem, Sophie;
    • Béné, Marie C.;
    • Moreau, Philippe;
    • Le Gouill, Steven;
    • Chevallier, Patrice
    Publication type:
    Article
    23

    Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B‐lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 374, doi. 10.1111/bjh.17801
    By:
    • Chatterjee, Gaurav;
    • Sriram, Harshini;
    • Ghogale, Sitaram;
    • Deshpande, Nilesh;
    • Khanka, Twinkle;
    • Girase, Karishma;
    • Verma, Shefali;
    • Arolkar, Gauri;
    • Dasgupta, Niharika;
    • Narula, Gaurav;
    • Shetty, Dhanalaxmi;
    • Dhamne, Chetan;
    • Moulik, Nirmalya R.;
    • Rajpal, Sweta;
    • Patkar, Nikhil V.;
    • Banavali, Shripad;
    • Gujral, Sumeet;
    • Subramanian, Papagudi G.;
    • Tembhare, Prashant R.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32

    A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash‐Mob' retrospective study incorporating 961 patients.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 433, doi. 10.1111/bjh.17692
    By:
    • Nicolson, Phillip L. R;
    • Perry, Rita;
    • Buka, Richard J.;
    • Fisher, Amelia;
    • Scott, Gemma;
    • Magill, Laura;
    • Okoth, Kelvin;
    • Chan‐Lam, Dominique;
    • Thorpe, Alice E.;
    • Macheta, Mac;
    • Carter‐Brzezinski, Luke;
    • Ackroyd, Sam;
    • Katumba, Alvin;
    • Bradbury, Charlotte;
    • Jen, Sheila;
    • Camilleri, Marquita;
    • Besser, Martin;
    • Bull, Tom;
    • Leighton, Katherine;
    • Ayalew, Yezenash
    Publication type:
    Article
    33

    Issue Information.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 257, doi. 10.1111/bjh.17584
    Publication type:
    Article
    34
    35
    36